Gut Organoid as a New Platform to Study Alginate and Chitosan Mediated PLGA Nanoparticles for Drug Delivery

被引:64
作者
Davoudi, Zahra [1 ]
Peroutka-Bigus, Nathan [2 ]
Bellaire, Bryan [2 ]
Jergens, Albert [3 ]
Wannemuehler, Michael [2 ]
Wang, Qun [1 ]
机构
[1] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA
[2] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA
[3] Iowa State Univ, Dept Vet Clin Sci, Ames, IA 50011 USA
关键词
organoids; alginate; chitosan; PLGA; nanoparticles; INFLAMMATORY-BOWEL-DISEASE; MODIFIED POLY(D; L-LACTIDE-CO-GLYCOLIDE); NANOSPHERES; INTESTINAL ORGANOIDS; IN-VITRO; MECHANISM; CELLS; LIPOSOMES; SYSTEM; MUCOSA; MODEL;
D O I
10.3390/md19050282
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Intestinal organoids can be used as an ex vivo epithelial model to study different drug delivery effects on epithelial cells' luminal surface. In this study, the impact of surface charge on the delivery of 5-ASA loaded PLGA nanoparticles into the lumen of organoids was investigated. Alginate and chitosan were used to coat the nanoparticles and provide negative and positive charges on the particles, respectively. The organoid growth and viability were not affected by the presence of either alginate- or chitosan-coated nanoparticles. It was shown that nanoparticles could be transported from the serosal side of the organoids to the lumen as the dye gradually accumulated in the lumen by day 2-3 after adding the nanoparticles to the Matrigel. By day 5, the dye was eliminated from the lumen of the organoids. It was concluded that the positively charged nanoparticles were more readily transported across the epithelium into the lumen. It may be attributed to the affinity of epithelial cells to the positive charge. Thus, the organoid can be utilized as an appropriate model to mimic the functions of the intestinal epithelium and can be used as a model to evaluate the benefits of nanoparticle-based drug delivery.
引用
收藏
页数:15
相关论文
共 51 条
[1]   Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa-Pharmaceutical Characterization and Fluorescence Imaging [J].
Ali, Hussain ;
Weigmann, Benno ;
Collnot, Eva-Maria ;
Khan, Saeed Ahmad ;
Windbergs, Maike ;
Lehr, Claus-Michael .
PHARMACEUTICAL RESEARCH, 2016, 33 (05) :1085-1092
[2]   Biodegradation and biocompatibility of PLA and PLGA microspheres [J].
Anderson, JM ;
Shive, MS .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) :5-24
[3]   EFFECT OF CHITOSAN ON THE PERMEABILITY OF MONOLAYERS OF INTESTINAL EPITHELIAL-CELLS (CACO-2) [J].
ARTURSSON, P ;
LINDMARK, T ;
DAVIS, SS ;
ILLUM, L .
PHARMACEUTICAL RESEARCH, 1994, 11 (09) :1358-1361
[4]   Mechanisms of Nanoparticle Internalization and Transport Across an Intestinal Epithelial Cell Model: Effect of Size and Surface Charge [J].
Bannunah, Azzah M. ;
Vllasaliu, Driton ;
Lord, Jennie ;
Stolnik, Snjezana .
MOLECULAR PHARMACEUTICS, 2014, 11 (12) :4363-4373
[5]   Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration [J].
Barker, Nick .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2014, 15 (01) :19-33
[6]   Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies [J].
Baumgart, Daniel C. ;
Sandborn, William J. .
LANCET, 2007, 369 (9573) :1641-1657
[7]   pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease [J].
Beloqui, Ana ;
Coco, Regis ;
Memvanga, Patrick B. ;
Ucakar, Bernard ;
des Rieux, Anne ;
Preat, Veronique .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 473 (1-2) :203-212
[8]   EFFECTS OF CYTOCHALASIN AND PHALLOIDIN ON ACTIN [J].
COOPER, JA .
JOURNAL OF CELL BIOLOGY, 1987, 105 (04) :1473-1478
[9]   Drug targeting strategies for the treatment of inflammatory bowel disease: a mechanistic update [J].
Dahan, Arik ;
Amidon, Gordon L. ;
Zimmermann, Ellen M. .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (04) :543-550
[10]   Natural polymers for gene delivery and tissue engineering [J].
Dang, Jiyoung M. ;
Leong, Kam W. .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (04) :487-499